DNAprint Genomics (DNAG)

[SlopsterSlasher]

Life Sciences, Bio-IT, and Healthcare Meeting Provides Opportunity to Describe Strategic Plans and Corporate Structure to Malaysian Business Community


KUALA LUMPUR, Malaysia – August 4, 2003 – DNA Phenomics Sdn Bhd, a development stage company focused on the emerging field of phenomics and engaged in the discovery of genomic-based diagnostic tests, recently accepted an invitation from the Malaysian Chapter of TiE (http://www.tiemalaysia.org/) to formally introduce the company to prominent members of Malaysia’s business and scientific community.

Mr. Kamaruz Fa’ad, DNA Phenomics’ Vice President of Marketing made the presentation to a group of over 100 Malaysian investment bankers, venture capitalists, corporate leaders and scientists. Assisting Mr. Fa’ad during the question and answer period following the presentation were Mr. Ezehan Reza Kamaluddin, Chief Operating Officer and Mr. Jason Lim, Project R & D Technician.

The presentation, “Taking DNA Detective Work to the Next Level: Solving Problems, Finding Cures,” outlined the role of genomics, proteomics and phenomics in the trait discovery process. As Mr Fa’ad stated, “the company’s mission is to become the pioneering phenomics company in the region and a leader in research, development, and the application of phenomic knowledge to the healthcare market.” To further make this point, Mr. Fa’ad briefly described three significant collaborative research projects already in the pipeline. “We have reached agreement with several of the region’s top institutes to conduct research into Hepatitis, Myopia and Syndrome X. Each of these projects is a significant scientific endeavor, especially for the populations in the Asia-Pacific region. As we continue to grow, DNA Phenomics will help spearhead the country’s efforts at making Malaysia the genomic/phenomic research and development center of the region.”

About DNA Phenomics
DNA Phenomics is a development stage company focused on the emerging field of phenomics and engaged in the discovery of genomic-based diagnostic tests for personalized medicine. The company's phenomics discovery platform offers university labs, and pharmaceutical and life science companies a powerful research tool for uncovering patterns in the genome associated with health factors and drug responses. The company’s goal is to become a leader in the discovery, development, and sale of genomic-based diagnostic healthcare products and biotech research services throughout Asia and the Pacific. Founded in 2003, DNA Phenomics is headquartered in Kuala Lumpur, Malaysia. DNA Phenomics is a privately held company. Additional information about DNA Phenomics and its genomic-based solutions can be found at www.DNAphenomics.com.

About Tie
TiE is the acronym for Talent Ideas Enterprise. Founded in 1992 in the Silicon Valley, it is an open and inclusive organization that has rapidly grown to more than forty chapters in nine countries. The TiE Malaysian Chapter was incorporated on January, 22nd, 2002. Its objectives include helping members integrate with the mainstream e-community, providing a networking platform for members and fostering entrepreneurships. Members of TiE are credited with creating over US $200 billion in wealth and hundreds of patents and inventions in the IT industry. Through the annual TiE World Conference, TiE hopes to achieve its many objectives.


Public Relations Contacts
Corporate Headquarters

Ezehan Reza Kamaluddin
Chief Operating Officer
DNA Phenomics
Kuala Lumpur, Malaysia
ezehan@dnaphenomics